Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16179582 | 0.86 | ALDH1A1 (0.43) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL19683450 | 0.85 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL155292 | 0.80 | ALDH1A1 (0.47) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL18101 | 0.78 | STAT3 (0.37) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL8152528 | 0.77 | ALDH1A1 (0.38) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL11637351 | 0.76 | ALDH1A1 (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL8653633 | 0.73 | ALDH1A1 (0.47) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL27991591 | 0.73 | ALDH1A1 (0.43) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL10950116 | 0.73 | STAT3 (0.36) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL690833 | 0.72 | STAT3 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3235016-B1 | A FERROELECTRIC ADHESIVE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2019-04-17 | — | — | EP | disclosed |
| CN-107438648-A | A kind of ferroelectricity adhesive composition | 汉高股份有限及两合公司 | 2017-12-05 | — | — | CN | disclosed |
| US-20170306190-A1 | FERROELECTRIC ADHESIVE COMPOSITION | Henkel IP & Holding GmbH (DE) | 2017-10-26 | — | — | US | disclosed |
| EP-3235016-A1 | A FERROELECTRIC ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016097077-A1 | A FERROELECTRIC ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2016-06-23 | — | — | WO | disclosed |
| US-20140295200-A1 | SELECTIVE COATING OF EXPOSED COPPER ON SILVER-PLATED COPPER | Henkel IP & Holding GmbH (DE) | 2014-10-02 | — | — | US | disclosed |
| US-7452943-B2 | Polymer compounds containing oxetane and styrenic functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-11-18 | — | — | US | disclosed |
| EP-1958943-A1 | Oxetane compounds containing styrenic functionality | National Starch and Chemical Investment Holding Corporation (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1620488-B1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | NAT STARCH CHEM INVEST (US) | 2008-06-18 | — | — | EP | disclosed |
| US-7319132-B2 | Polymer compounds containing oxetane and maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-01-15 | — | — | US | disclosed |
| US-20050192446-A1 | Polymer compounds containing oxetane and styrenic functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2005-09-01 | — | — | US | disclosed |
| WO-2004101541-A1 | OXETANE COMPOUNDS CONTAINING STYRENIC FUNCTIONALITY | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101542-A1 | OXETANE COMPOUNDS CONTAINING CINNAMYL FUNCTIONALITY | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101550-A1 | OXETANE COMPOUNDS CONTAINING MALEIMIDE FUNCTIONALITY | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101646-A1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| US-20040225070-A1 | Oxetane compounds containing maleimide functionality | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-20040225074-A1 | Adhesive compositions containing hybrid oxetane compounds | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-20040225081-A1 | Oxetane compounds containing cinnamyl functionality | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-20040225071-A1 | Oxetane compounds containing styrenic functionality | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-6753434-B1 | CURABLE; CATIONIC AND ANIONIC RING OPENING OR FREE RADICAL POLYMERIZABLE | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2004-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040225071-A1 | Oxetane compounds containing styrenic functionality | OXER1, OXGR1, TET1 | ALDH1A1 2304/4885CYP3A4 249/4885CYP2C9 213/4885 |
| US-20040225081-A1 | Oxetane compounds containing cinnamyl functionality | DUOX2, OXER1, OXGR1 | ALDH1A1 2461/4885CYP3A4 101/4885CYP2C9 115/4885 |
| US-20050192446-A1 | Polymer compounds containing oxetane and styrenic functionality | OXGR1, OXER1, TET1 | ALDH1A1 2291/4885CYP3A4 453/4885CYP2C9 445/4885 |
| US-20040225070-A1 | Oxetane compounds containing maleimide functionality | OXGR1, DUOX2, JMJD6 | ALDH1A1 2841/4885CYP3A4 121/4885CYP2C9 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.